The relationship between the gut microbiome and host gene expression: a review

RG Nichols, ER Davenport - Human genetics, 2021 - Springer
Despite the growing knowledge surrounding host–microbiome interactions, we are just
beginning to understand how the gut microbiome influences—and is influenced by—host …

Anticancer drug discovery from microbial sources: The unique mangrove streptomycetes

JWF Law, LNS Law, V Letchumanan, LTH Tan… - Molecules, 2020 - mdpi.com
Worldwide cancer incidence and mortality have always been a concern to the community.
The cancer mortality rate has generally declined over the years; however, there is still an …

RNA‐PROTACs: degraders of RNA‐binding proteins

A Ghidini, A Cléry, F Halloy, FHT Allain… - Angewandte …, 2021 - Wiley Online Library
Defects in the functions of RNA binding proteins (RBPs) are at the origin of many diseases;
however, targeting RBPs with conventional drugs has proven difficult. PROTACs are a new …

Discovery of a novel ferroptosis inducer-talaroconvolutin A—killing colorectal cancer cells in vitro and in vivo

Y Xia, S Liu, C Li, Z Ai, W Shen, W Ren, X Yang - Cell Death & Disease, 2020 - nature.com
Ferropotsis is among the most important mechanisms of cancer suppression, which could be
harnessed for cancer therapy. However, no natural small-molecule compounds with cancer …

Alternative splicing as a target for cancer treatment

N Martinez-Montiel, NH Rosas-Murrieta… - International journal of …, 2018 - mdpi.com
Alternative splicing is a key mechanism determinant for gene expression in metazoan.
During alternative splicing, non-coding sequences are removed to generate different mature …

Alternative splicing: the pledge, the turn, and the prestige: the key role of alternative splicing in human biological systems

LM Gallego-Paez, MC Bordone, AC Leote… - Human genetics, 2017 - Springer
Alternative pre-mRNA splicing is a tightly controlled process conducted by the spliceosome,
with the assistance of several regulators, resulting in the expression of different transcript …

Therapeutic targeting of alternative splicing: a new frontier in cancer treatment

AJ Murphy, AH Li, P Li, H Sun - Frontiers in oncology, 2022 - frontiersin.org
The ability for cells to harness alternative splicing enables them to diversify their proteome in
order to carry out complex biological functions and adapt to external and internal stimuli. The …

Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment

ML Leite, NB da Cunha, FF Costa - Pharmacology & therapeutics, 2018 - Elsevier
Despite the advances in tumor identification and treatment, cancer remains the primary
driver of death around the world. Also, regular treatments for the disease are incapable of …

Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation

P Popli, MM Richters, SB Chadchan, TH Kim… - Cell death & …, 2020 - nature.com
Although endometrial cancer is the most common cancer of the female reproductive tract, we
have little understanding of what controls endometrial cancer beyond the transcriptional …

circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis

Q Xu, B Deng, M Li, Y Chen, L Zhuan - Journal of ovarian research, 2020 - Springer
Objective circular RNAs (circRNAs) have been reported to be essential regulators of multiple
malignant cancers. However, the functions of circRNAs in ovarian cancer need to be further …